FREMONT, Calif., Jan. 8 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.
(PDL) (Nasdaq: PDLI) today announced that Mark McDade, Chief Executive
Officer, and Andrew Guggenhime, Chief Financial Officer, will participate
in the upcoming 25th Annual JP Morgan Healthcare Conference in San
Francisco on Thursday, January 11, 2007, at 10:00 a.m. Pacific time.
A live webcast of the presentation will be available through the PDL
website: http://www.pdl.com . Please connect to this website at least 15
minutes prior to the live webcast to allow time for any software download
that may be needed to hear the webcast. A replay will be available at
http://www.pdl.com starting approximately one hour after completion of the
webcast.
About PDL BioPharma
PDL BioPharma, Inc. is a biopharmaceutical company focused on
discovering, developing and commercializing innovative therapies for severe
or life-threatening illnesses, with a commercial focus on the acute-care
hospital setting. For more information, please see PDL's website at
http://www.pdl.com
NOTE: PDL BioPharma and the PDL BioPharma logo are considered
trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
 back to top
Related links:
http://www.pdl.com
CONTACT:
Ami Knoefler, Corporate and Investor
Relations, of PDL BioPharma, Inc., +1-510-284-8851, or
ami.knoefler@pdl.com
|
